Eye tests for people taking Tivdak for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial is for people with cervical cancer that has come back or spread and is getting worse after chemotherapy. It will check your eyes regularly while you take Tivdak to see how the drug affects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has come back or spread and it got worse after chemotherapy.
- Your doctor has decided that Tivdak is the right treatment for you.
- You are willing to have several eye exams and regular clinic visits.
- You agree to use effective birth control if needed.
- You have not taken Tivdak before.
- You do not have any active eye disease right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This early-stage trial tests a new drug called IBI3031 to treat active thyroid eye disease (TED), a condition where the immune system attacks muscles and tissue around the eyes, causing swelling, bulging, and sometimes double vision. The study aims to see if this drug can reduce inflammation and improve symptoms.
This study collects information and eye health data from people who have had cancer treatment, including stem cell transplants. It helps doctors understand how cancer therapies affect the eyes over time.
This trial tests a medication called IBI311 for people with inactive thyroid eye disease that still causes bothersome symptoms like double vision or trouble closing the eyes. The goal is to see if it helps improve these problems safely.
This study tests an investigational medication for thyroid eye disease, which causes bulging eyes and discomfort. The treatment is given as an injection near the eye, and the study will last about 12 months to see how safe and effective it is.
This study tests an investigational drug called SCTT11 in healthy people and in people with thyroid eye disease. The goal is to see if it is safe and if it can help reduce symptoms like bulging eyes and discomfort.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.